Physician profile
Jay M Patel
NPI 1396000287
$1,341.29
in general payments reported to CMS, 2019-2025
11 companies · $70.68 in 2025
The $70.68 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.85 · 2020: $17.45 · 2021: $396 · 2023: $158 · 2024: $673 · 2025: $70.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $305.49 | 2021-2023 | Harmony |
| Astrazeneca Pharmaceuticals LP | $238.34 | 2021-2024 | Farxiga |
| Cvrx, INC. | $201.30 | 2024 | Barostim Neo System |
| Abiomed | $163.20 | 2024 | Impella |
| Abbott Laboratories | $150.92 | 2024-2025 | Cardiomems, Triclip |
| Janssen Pharmaceuticals, INC | $86.87 | 2023-2024 | Xarelto |
| Pfizer INC. | $79.27 | 2023 | |
| Insmed, INC. | $49.33 | 2024-2025 | Arikayce |
| Amgen INC. | $43.30 | 2019-2020 | |
| Ambu INC. | $20.46 | 2025 | |
| Elutia, INC. | $2.81 | 2025 | Ecm Patch,Pouch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.